Literature DB >> 10857886

Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.

K Kanazawa1, T Suzuki, K Sakumoto.   

Abstract

To describe our experience with malignant ovarian germ cell tumors with special reference to reproductive performance after remission, medical records of 31 patients were reviewed. The mean age at diagnosis was 18.6 years. Tumor by stage was I in 16 cases, II in 5, III in 5, IV in 3, and recurrence in 2. Histology was dysgerminoma in 7 cases, yolk sac tumor in 10, immature teratoma in 7, choriocarcinoma in 1, and mixed-type tumor in 6. Conservative surgery for fertility preservation was performed in 21 cases. Postoperative chemotherapy was given to all cases except two with stage Ia dysgerminoma. Of 31 cases, 4 including one fertility-preserved case died of disease. The other 27 cases including 20 fertility-preserved cases were successfully treated. Twenty-five cases (92.6%) have been followed longer than 60 months and 13 cases (48.1%) longer than 120 months. By the last follow-up, 8 of the 20 fertility-preserved cases delivered a total of 9 normal babies. Of the remaining 12 nonpregnant cases, 3 married, 9 have had regular menses, and 3 have had menstrual problems. Two of the latter three cases have been in hypergonadotropic anovulatory cycles. One patient has been diagnosed with tubal infertility caused by peritubal adhesion. Thus, management of the disease with fertility preservation is safe and the majority of patients can attain or retain normal ovarian function and reproductive potential.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857886     DOI: 10.1097/00000421-200006000-00007

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  7 in total

Review 1.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

2.  A favorable maternal and neonatal outcome following chemotherapy with etoposide, bleomycin, and cisplatin for management of grade 3 immature teratoma of the ovary.

Authors:  Fatemeh Ghaemmaghami; Fatemeh Abbasi; Akram Ghahghai Nezam Abadi
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

3.  The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours.

Authors:  S P Blagden; M A Foskett; R A Fisher; D Short; S Fuller; E S Newlands; M J Seckl
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

4.  Successful infertility treatment following fertility-sparing surgery and chemotherapy for ovarian immature teratoma: a case report and a literature review.

Authors:  Hiroshi Matsushita; Hirohiko Tani
Journal:  Reprod Med Biol       Date:  2011-04-26

5.  Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.

Authors:  J Gaffan; L Holden; E S Newlands; D Short; S Fuller; R H J Begent; G J S Rustin; M J Seckl
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

6.  Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.

Authors:  Ahmad Bakr Alwazzan; Shaundra Popowich; Erin Dean; Christine Robinson; Robert Lotocki; Alon D Altman
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

7.  Tailored therapy and long-term surveillance of malignant germ cell tumors in the female genital system: 10-year experience.

Authors:  Qianying Zhao; Jiaxin Yang; Dongyan Cao; Jiangna Han; Kaifeng Xu; Yongjian Liu; Keng Shen
Journal:  J Gynecol Oncol       Date:  2016-05       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.